Skip to main content
Recall Canary
Dicyclomine Hydrochloride Capsules 10mg
← Back to all recalls
DRUG RECALLMODERATE

Dicyclomine Hydrochloride Capsules 10mg

Aurobindo recalls Dicyclomine HCl 10mg capsules due to shortfill and empty capsules.

What to do

Consumers who have the affected Dicyclomine Hydrochloride Capsules, USP, 10mg, NDC 59651-719-99, should stop using them and contact their pharmacist or healthcare provider for a replacement or guidance. Return the product to the place of purchase for a refund or exchange.

Recalled
Listed
Updated
Recall No.
D-0733-2026
Agency
FDA
Firm
Aurobindo Pharma USA Inc
Recall ID
99492
Status
ONGOING

Recall at a glance

Quantity recalled
6,408 bottles distributed to market

Why it was recalled

Aurobindo Pharma USA is recalling Dicyclomine Hydrochloride Capsules, USP, 10mg, due to reports of shortfill and empty capsules. Consumers may receive capsules that are not full, potentially affecting the intended dose.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Dicyclomine Hydrochloride Capsules, USP

Lot code
DMC125018A, 2027
Strength
10 mg
NDC / UPC
NDC 59651-719-99

Where it was sold

Distributed nationwide.

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Other Product Quality Defect recalls

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-08-05 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification